Emerald BioSystems

Bainbridge Island, United States Founded: 1998 • Age: 28 yrs Acquired By Beryllium
Laboratory automation, bioinformatics software, reagent kits and plastic-ware products
Request Access

About Emerald BioSystems

Emerald BioSystems is a company based in Bainbridge Island (United States) founded in 1998 was acquired by Beryllium in November 2009.. Emerald BioSystems operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.

  • Headquarter Bainbridge Island, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Emerald Biosystems Holding Co., Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Beryllium

    (Nov 13, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Emerald BioSystems

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Emerald BioSystems

Emerald BioSystems has secured backing from 1 investor. Prominent investors backing the company include Be4. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Drug discovery solutions are offered by Beryllium through specialized services.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Emerald BioSystems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Emerald BioSystems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Emerald Biosystems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Emerald BioSystems

Emerald BioSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cloud-based protein-modeling software is developed for drug discovery.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
Proteomics platform developed for early cancer and neurological disease detection.
domain founded_year HQ Location
Proteomics services are delivered via discovery and targeted platforms.
domain founded_year HQ Location
Provider tools to help researchers with protein analysis
domain founded_year HQ Location
Small molecule oncology therapeutics are developed for cancer treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Emerald Biosystems

Frequently Asked Questions about Emerald BioSystems

When was Emerald BioSystems founded?

Emerald BioSystems was founded in 1998.

Where is Emerald BioSystems located?

Emerald BioSystems is headquartered in Bainbridge Island, United States. It is registered at Bainbridge Island, Washington, United States.

What does Emerald BioSystems do?

Emerald BioSystems was founded in 1998 in Bainbridge Island, United States, within the biotechnology sector focused on structural biology. Tools such as laboratory automation systems, bioinformatics software, reagent kits, and plastic-ware were supplied to support gene-to-protein-structure workflows. Automated cell-free protein expression, purification, and crystallization processes were enabled by these solutions, including the Microcapillary Protein Crystallization System and CrystalCards for microfluidic applications. Acquisition by Beryllium took place in November 2009.

Who are the top competitors of Emerald BioSystems?

Emerald BioSystems's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.

Who are Emerald BioSystems's investors?

Emerald BioSystems has 1 investor. Key investors include Be4.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available